The Bioengineering Board of Directors is pleased to announce the appointment of COO Marc Bachmann as the new Bioengineering Chief Executive Officer with immediate effect. He succeeds Gabriella Meyer, who has served as CEO since 2009 and will continue to lead the company in a strategic position as Executive Chairman of the Board of Directors.